Guyabano (Soursop) Leaves: Traditional Use vs. Scientific Evidence

Guyabano (Annona muricata, soursop/graviola) leaves are used in traditional medicine for various ailments. However, no clinical trials support curative claims for any disease.

Phytochemistry

• Acetogenins (annonaceous acetogenins – ACGs): cytotoxic in vitro.
• Alkaloids (coreximine, reticuline), flavonoids, tannins, essential oils.

Preclinical Data (In Vitro / Animal)

• Anticancer: ACGs inhibit mitochondrial complex I → ATP depletion → apoptosis in cancer cell lines (breast, prostate, colon, pancreatic, liver). Selective toxicity claimed but not proven in vivo.
• Antimicrobial, antiparasitic, anti-inflammatory, antidiabetic, hepatoprotective – animal models only.

Critical Gaps

• No human clinical trials for cancer or any disease treatment.
• Toxicity concerns: Annonacin (major ACG) → atypical parkinsonism (Guadeloupe Parkinsonism cluster linked to chronic consumption). Mitochondrial neurotoxicity.
• Pharmacokinetics unknown: Absorption, metabolism, dosing, drug interactions.
• Quality control: Supplements unstandardized; contamination risk.

Regulatory Status

• FDA: Warning letters to companies making cancer cure claims.
• Not approved as drug for any indication.
• Sold as dietary supplement (DSHEA) – no efficacy proof required.

Responsible Use

• Do not replace conventional cancer therapy.
• Inform oncologist if using (interactions, toxicity).
• Tea/infusion occasionally likely low risk; chronic high-dose supplements risky.
• Focus on evidence-based nutrition: fruits, vegetables, whole grains.

Conclusion: Traditional use ≠ proven cure. Preclinical promise does not translate to clinical efficacy. Neurotoxicity risk warrants caution.